中国医药
中國醫藥
중국의약
CHINA MEDICINE
2012年
6期
741-743
,共3页
邹明%韩莹旻%梁卉%陈艳伟%汤新强
鄒明%韓瑩旻%樑卉%陳豔偉%湯新彊
추명%한형민%량훼%진염위%탕신강
头孢菌素类,头孢硫脒%氯化钠注射液%葡萄糖注射液%色谱法,高压液相%稳定性
頭孢菌素類,頭孢硫脒%氯化鈉註射液%葡萄糖註射液%色譜法,高壓液相%穩定性
두포균소류,두포류미%록화납주사액%포도당주사액%색보법,고압액상%은정성
Cephalosporins,cefathiamidine%Sodium chloride injection%Dextrose injection%Chromatography,high performance liquid%Stability
目的 考察注射用头孢硫脒在4种临床常用注射液中的配伍稳定性.方法 根据《中华人民共和国药典》(2010版)规定的注射液pH值的上下限,调节0.9%氯化钠注射液、5%葡萄糖注射液、10%葡萄糖注射液以及5%葡萄糖+0.9%氯化钠注射液的pH值,并按临床常用剂量,配制头孢硫脒与上述注射液及原pH值注射液的配伍溶液,考察上述12种配伍液于0、0.5、1、2、3、4、5、6h的pH值、颜色和澄明度等外观变化,用高效液相色谱法考察在上述时间点下配伍液中头孢硫脒的含量变化.该方法采用BDS-C18(250 mm×4.6 mm,5 μm)色谱柱,磷酸盐缓冲液:乙腈(80∶20)为流动相,检测波长为254 nm,柱温为30℃,进样量1μl.结果 头孢硫脒专属性好,能达到基线分离,线性范围为1~12 mg/ml(R=1.0000),日内精密度相对标准差<2.0%,12种配伍液在6h内峰面积变化均<4%.结论 头孢硫脒与不同pH值的0.9%氯化钠注射液、5%葡萄糖注射液、10%葡萄糖注射液以及5%葡萄糖+0.9%氯化钠注射液配伍后稳定,临床上可配伍使用.
目的 攷察註射用頭孢硫脒在4種臨床常用註射液中的配伍穩定性.方法 根據《中華人民共和國藥典》(2010版)規定的註射液pH值的上下限,調節0.9%氯化鈉註射液、5%葡萄糖註射液、10%葡萄糖註射液以及5%葡萄糖+0.9%氯化鈉註射液的pH值,併按臨床常用劑量,配製頭孢硫脒與上述註射液及原pH值註射液的配伍溶液,攷察上述12種配伍液于0、0.5、1、2、3、4、5、6h的pH值、顏色和澄明度等外觀變化,用高效液相色譜法攷察在上述時間點下配伍液中頭孢硫脒的含量變化.該方法採用BDS-C18(250 mm×4.6 mm,5 μm)色譜柱,燐痠鹽緩遲液:乙腈(80∶20)為流動相,檢測波長為254 nm,柱溫為30℃,進樣量1μl.結果 頭孢硫脒專屬性好,能達到基線分離,線性範圍為1~12 mg/ml(R=1.0000),日內精密度相對標準差<2.0%,12種配伍液在6h內峰麵積變化均<4%.結論 頭孢硫脒與不同pH值的0.9%氯化鈉註射液、5%葡萄糖註射液、10%葡萄糖註射液以及5%葡萄糖+0.9%氯化鈉註射液配伍後穩定,臨床上可配伍使用.
목적 고찰주사용두포류미재4충림상상용주사액중적배오은정성.방법 근거《중화인민공화국약전》(2010판)규정적주사액pH치적상하한,조절0.9%록화납주사액、5%포도당주사액、10%포도당주사액이급5%포도당+0.9%록화납주사액적pH치,병안림상상용제량,배제두포류미여상술주사액급원pH치주사액적배오용액,고찰상술12충배오액우0、0.5、1、2、3、4、5、6h적pH치、안색화징명도등외관변화,용고효액상색보법고찰재상술시간점하배오액중두포류미적함량변화.해방법채용BDS-C18(250 mm×4.6 mm,5 μm)색보주,린산염완충액:을정(80∶20)위류동상,검측파장위254 nm,주온위30℃,진양량1μl.결과 두포류미전속성호,능체도기선분리,선성범위위1~12 mg/ml(R=1.0000),일내정밀도상대표준차<2.0%,12충배오액재6h내봉면적변화균<4%.결론 두포류미여불동pH치적0.9%록화납주사액、5%포도당주사액、10%포도당주사액이급5%포도당+0.9%록화납주사액배오후은정,림상상가배오사용.
Objective To study the compatible stability of cefathiamidine for injection with four infusions with different pH values.Methods According to the pH range of four infusions in China pharmacopoeia(CP),pH of 0.9% sodium chloride injections,5% dextrose injections,10% dextrose injections and 5% dextrose +0.9% sodium chloride injections were adjusted.According to the clinical common dose,the compatibility solutions between cefathiamidine and infusions and infusions unadjusted were confected.pH value,color and external appearance changes (color and clarity) of the 12 compatibility solutions were determined at 0,0.5,1,2,3,4,5 and 6 h.The high performance liquid chromatography(HPLC) assay was performed for determining the content of the four compatibility solutions at the same time.BDS-C18 chromatographic column (250 mm ×4.6 mm,5 μm) was used;the mobile phase was phosphate buffer liquid and acetonitrile (80∶20) ; the detective wavelength was 254 nm; the temperature was 30 ℃ and the incoming sample amounted to 1 μl.Results This method achieved baseline separation.The linear range was within 1-12 mg/ml.Relative standard deviation(RSD) of intra-day was less than 2%.Peak area was relative steady and decreasing degree was less than 4% within 6 hours.Conclusion After the compatibility of cefathiamidine and 0.9% sodium chloride injection,cefathiamidine and 5% dextrose injection,cefathiamidine and 10% dextrose injection and cefathiamidine and 5% dextrose +0.9% sodium chloride injection with different pH values during 6 hours at room temperature can keep an relative stability and can be used for clinie.